Orchestra BioMed Holdings (OBIO) Short-term Investments (2022 - 2026)

Orchestra BioMed Holdings (OBIO) has 5 years of Short-term Investments data on file, last reported at $66.0 million in Q1 2026.

• On a quarterly basis, Short-term Investments rose 109.39% year-over-year to $66.0 million in Q1 2026; TTM through Mar 2026 was $66.0 million, a 109.39% increase from a year earlier, with the FY2025 full-year figure at $71.8 million, up 61.21% from the prior year.
• Short-term Investments for Q1 2026 stood at $66.0 million, down from $71.8 million in the prior quarter.
• Over the last five years, Short-term Investments for OBIO reached as high as $108.4 million in Q1 2023 and fell as low as $23000.0 in Q1 2024.
• Historically, Short-term Investments has averaged $52.3 million across 5 years, with a median of $53.8 million in 2025.
• Across the five-year window, Short-term Investments slumped 99.98% in 2024 and soared 137013.04% in 2025, its largest moves.
• Year by year, Short-term Investments stood at $86000.0 in 2022, then jumped by 66141.86% to $57.0 million in 2023, then decreased by 21.8% to $44.6 million in 2024, then surged by 61.21% to $71.8 million in 2025, then slipped by 8.06% to $66.0 million in 2026.
• Per Business Quant data, the three most recent Short-term Investments figures were $66.0 million in Q1 2026, $71.8 million in Q4 2025, and $53.8 million in Q3 2025.